Resolvin E1 (RvE1) attenuates atherosclerotic plaque formation in diet and inflammation-induced atherogenesis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 5, 2015, Pages 1123-1133

  Hasturk, Hatice ^a   Abdallah, Rima ^b   Kantarci, Alpdogan ^a   Nguyen, Daniel ^a   Giordano, Nicholas ^d   Hamilton, James ^c   Van Dyke, Thomas E ^a  

^a FORSYTH INSTITUTE   (United States)

^b BEIRUT ARAB UNIVERSITY   (Lebanon)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Boston University   (United States)

Author keywords

atherosclerosis; inflammation; models, animal

Indexed keywords

C REACTIVE PROTEIN; POLYUNSATURATED FATTY ACID; RESOLVIN E1; UNCLASSIFIED DRUG; 5S,12R,18R-TRIHYDROXY-6Z,8E,10E,14Z,16E-EICOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID;

ALVEOLAR BONE LOSS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG MEGADOSE; EX VIVO STUDY; HISTOPATHOLOGY; INFLAMMATION; INFLAMMATORY INFILTRATE; LOW DRUG DOSE; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RABBIT; TREATMENT OUTCOME; VASCULITIS; ANALOGS AND DERIVATIVES; ANIMAL; ATHEROGENIC DIET; ATHEROSCLEROSIS; COMPARATIVE STUDY; COMPLICATION; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; METABOLISM; NEEDLE BIOPSY; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZATION; REFERENCE VALUE; RISK ASSESSMENT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ATHEROSCLEROSIS; BIOPSY, NEEDLE; C-REACTIVE PROTEIN; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; EICOSAPENTAENOIC ACID; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; PERIODONTITIS; RABBITS; RANDOM ALLOCATION; REFERENCE VALUES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84930217671     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.305324     Document Type: Article

References (53)

1. Libby P, Plutzky J, Diabetic macrovascular disease: the glucose paradox? Circulation 2002 106 2760 2763
2. Libby P, Ridker PM, Maseri A, Inflammation and atherosclerosis. Circulation 2002 105 1135 1143
3. Marx N, Kehrle B, Kohlhammer K, Grüb M, Koenig W, Hombach V, Libby P, Plutzky J, PPAR activators as antIInflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-Associated arteriosclerosis. Circ Res 2002 90 703 710
4. Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, Petasis NA, Levy BD, Serhan CN, Van Dyke TE, RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB J 2006 20 401 403. doi: 10.1096/fj.05-4724fje
5. Atar S, Fu Y, Wagner GS, Rosanio S, Barbagelata A, Birnbaum Y, Usefulness of ST depression with T-wave inversion in leads V(4) to V(6) for predicting one-year mortality in non-ST-elevation acute coronary syndrome (from the Electrocardiographic Analysis of the Global Use of Strategies to Open Occluded Coronary Arteries IIB Trial). Am J Cardiol 2007 99 934 938. doi: 10.1016/j.amjcard.2006.11.039
6. Schwab JM, Chiang N, Arita M, Serhan CN, Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007 447 869 874. doi: 10.1038/nature05877
7. Aoki H, Hisada T, Ishizuka T, Utsugi M, Ono A, Koga Y, Sunaga N, Nakakura T, Okajima F, Dobashi K, Mori M, Protective effect of resolvin E1 on the development of asthmatic airway inflammation. Biochem Biophys Res Commun 2010 400 128 133. doi: 10.1016/j.bbrc.2010.08.025
8. Seki H, Fukunaga K, Arita M, Arai H, Nakanishi H, Taguchi R, Miyasho T, Takamiya R, Asano K, Ishizaka A, Takeda J, Levy BD, The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J Immunol 2010 184 836 843. doi: 10.4049/jimmunol.0901809
9. Serhan CN, Chiang N, Van Dyke TE, Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008 8 349 361. doi: 10.1038/nri2294
10. Dietrich T, Sharma P, Walter C, Weston P, Beck J, The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. J Periodontol 2013 84 4 Suppl S70 S84. doi: 10.1902/jop.2013.134008
11. Kodovazenitis G, Pitsavos C, Papadimitriou L, Deliargyris EN, Vrotsos I, Stefanadis C, Madianos PN, Periodontal disease is associated with higher levels of C-reactive protein in non-diabetic, non-smoking acute myocardial infarction patients. J Dent 2011 39 849 854. doi: 10.1016/j.jdent.2011.09.005
12. Schenkein HA, Loos BG, Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J Periodontol 2013 84 4 Suppl S51 S69. doi: 10.1902/jop.2013.134006
13. Phinikaridou A, Hallock KJ, Qiao Y, Hamilton JA, A robust rabbit model of human atherosclerosis and atherothrombosis. J Lipid Res 2009 50 787 797. doi: 10.1194/jlr.M800460-JLR200
14. Dornas WC, Oliveira TT, Augusto LE, Nagem TJ, Experimental atherosclerosis in rabbits. Arq Bras Cardiol 2010 95 272 278
15. Hasturk H, Kantarci A, Goguet-Surmenian E, Blackwood A, Andry C, Serhan CN, Van Dyke TE, Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol 2007 179 7021 7029
16. Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B, Colgan SP, Stahl GL, Merched A, Petasis NA, Chan L, Van Dyke TE, Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 2003 171 6856 6865
17. Segura AM, Gregoric I, Radovancevic R, Demirozu ZT, Buja LM, Frazier OH, Morphologic changes in the aortic wall media after support with a continuous-flow left ventricular assist device. J Heart Lung Transplant 2013 32 1096 1100. doi: 10.1016/j.healun.2013.07.007
18. Finn AV, Kolodgie FD, Virmani R, Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology. Arterioscler Thromb Vasc Biol 2010 30 177 181. doi: 10.1161/ATVBAHA.108.173609
19. Matsuo K, Akakabe Y, Kitamura Y, Shimoda Y, Ono K, Ueyama T, Matoba S, Yamada H, Hatakeyama K, Asada Y, Emoto N, Ikeda K, Loss of Apoptosis Regulator through Modulating IAP Expression (ARIA) protects blood vessels from atherosclerosis. J Biol Chem 2015 290 3784 3792. doi: 10.1074/jbc.M114.605287
20. Jain A, Batista EL Jr, Serhan C, Stahl GL, Van Dyke TE, Role for periodontitis in the progression of lipid deposition in an animal model. Infect Immun 2003 71 6012 6018
21. Libby P, Ridker PM, Inflammation and atherosclerosis: role of c-reactive protein in risk assessment. Am J Med 2004 116 Suppl 6A 9S 16S
22. Cheng JM, Oemrawsingh RM, Garcia-Garcia HM, Akkerhuis KM, Kardys I, de Boer SP, Langstraat JS, Regar E, van Geuns RJ, Serruys PW, Boersma E, Relation of C-reactive protein to coronary plaque characteristics on grayscale, radiofrequency intravascular ultrasound, and cardiovascular outcome in patients with acute coronary syndrome or stable angina pectoris (from the ATHEROREMO-IVUS study). Am J Cardiol 2014 114 1497 1503. doi: 10.1016/j.amjcard.2014.08.013
23. Geng YJ, Libby P, Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol 2002 22 1370 1380
24. Gomes-Filho IS, Freitas Coelho JM, da Cruz SS, Passos JS, Teixeira de Freitas CO, Aragão Farias NS, Amorim da Silva R, Silva Pereira MN, Lima TL, Barreto ML, Chronic periodontitis and C-reactive protein levels. J Periodontol 2011 82 969 978. doi: 10.1902/jop.2010.100511
25. Brito LC, DalBó S, Striechen TM, Farias JM, Olchanheski LR Jr, Mendes RT, Vellosa JC, Fávero GM, Sordi R, Assreuy J, Santos FA, Fernandes D, Experimental periodontitis promotes transient vascular inflammation and endothelial dysfunction. Arch Oral Biol 2013 58 1187 1198. doi: 10.1016/j.archoralbio.2013.03.009
26. Hayashi T, Matsui-Hirai H, Fukatsu A, Sumi D, Kano-Hayashi H, Rani P JA, Iguchi A, Selective iNOS inhibitor, ONO1714 successfully retards the development of high-cholesterol diet induced atherosclerosis by novel mechanism. Atherosclerosis 2006 187 316 324. doi: 10.1016/j.atherosclerosis.2005.10.023
27. Bäck M, Airila-Månsson S, Jogestrand T, Söder B, Söder PO, Increased leukotriene concentrations in gingival crevicular fluid from subjects with periodontal disease and atherosclerosis. Atherosclerosis 2007 193 389 394. doi: 10.1016/j.atherosclerosis.2006.07.003
28. Ho KJ, Spite M, Owens CD, Lancero H, Kroemer AH, Pande R, Creager MA, Serhan CN, Conte MS, Aspirin-Triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am J Pathol 2010 177 2116 2123. doi: 10.2353/ajpath.2010.091082
29. Fedele S, Sabbah W, Donos N, Porter S, D'Aiuto F, Common oral mucosal diseases, systemic inflammation, and cardiovascular diseases in a large cross-sectional US survey. Am Heart J 2011 161 344 350. doi: 10.1016/j.ahj.2010.11.009
30. Tonetti MS, Van Dyke TE, Working Group 1 of the Joint EFP/AAP Workshop Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontol 2013 84 4 Suppl S24 S29. doi: 10.1902/jop.2013.1340019
31. Dalli J, Colas RA, Serhan CN, Novel n-3 immunoresolvents: structures and actions. Sci Rep 2013 3 1940. doi: 10.1038/srep01940
32. Calder PC, n-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions. Proc Nutr Soc 2013 72 326 336. doi: 10.1017/S0029665113001031
33. Spite M, Deciphering the role of n-3 polyunsaturated fatty acid-derived lipid mediators in health and disease. Proc Nutr Soc 2013 72 441 450. doi: 10.1017/S0029665113003030
34. Salinas G, Rangasetty UC, Uretsky BF, Birnbaum Y, The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame. J Cardiovasc Pharmacol Ther 2007 12 98 111. doi: 10.1177/1074248407301172
35. Merched AJ, Ko K, Gotlinger KH, Serhan CN, Chan L, Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J 2008 22 3595 3606. doi: 10.1096/fj.08-112201
36. Fredman G, Van Dyke TE, Serhan CN, Resolvin E1 regulates adenosine diphosphate activation of human platelets. Arterioscler Thromb Vasc Biol 2010 30 2005 2013. doi: 10.1161/ATVBAHA.110.209908
37. Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH, Hong S, Serhan CN, Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol 2005 174 4345 4355
38. Kobayashi T, Okada M, Ito S, Kobayashi D, Ishida K, Kojima A, Narita I, Murasawa A, Yoshie H, Assessment of interleukin-6 receptor inhibition therapy on periodontal condition in patients with rheumatoid arthritis and chronic periodontitis. J Periodontol 2014 85 57 67. doi: 10.1902/jop.2013.120696
39. Subramanian S, Emami H, Vucic E, Singh P, Vijayakumar J, Fifer KM, Alon A, Shankar SS, Farkouh M, Rudd JH, Fayad ZA, Van Dyke TE, Tawakol A, High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins. J Am Coll Cardiol 2013 62 2382 2391. doi: 10.1016/j.jacc.2013.08.1627
40. Birnbaum Y, Ye Y, Lin Y, Freeberg SY, Huang MH, Perez-Polo JR, Uretsky BF, Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart. Prostaglandins Other Lipid Mediat 2007 83 89 98. doi: 10.1016/j.prostaglandins.2006.10.003
41. Spite M, Serhan CN, Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ Res 2010 107 1170 1184. doi: 10.1161/CIRCRESAHA.110.223883
42. Interleukin-6 Receptor Mendelian Randomisation Analysis C The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet 2012 379 1214 1224
43. Oemrawsingh RM, Cheng JM, García-García HM, van Geuns RJ, de Boer SP, Simsek C, Kardys I, Lenzen MJ, van Domburg RT, Regar E, Serruys PW, Akkerhuis KM, Boersma E, ATHEROREMO-NIRS Investigators Near-infrared spectroscopy predicts cardiovascular outcome in patients with coronary artery disease. J Am Coll Cardiol 2014 64 2510 2518. doi: 10.1016/j.jacc.2014.07.998
44. Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y, A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J Periodontol 2005 76 2075 2084
45. Genco RJ, Van Dyke TE, Prevention: Reducing the risk of CVD in patients with periodontitis. Nat Rev Cardiol 2010 7 479 480. doi: 10.1038/nrcardio.2010.120
46. Gibson FC 3rd, Gonzalez DA, Wong J, Genco CA, Porphyromonas gingivalis-specific immunoglobulin G prevents P. gingivalis-elicited oral bone loss in a murine model. Infect Immun 2004 72 2408 2411
47. Reyes L, Herrera D, Kozarov E, Roldá S, Progulske-Fox A, Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology. J Periodontol 2013 84 4 Suppl S30 S50. doi: 10.1902/jop.2013.1340012
48. Richardson M, De Reske M, Delaney K, Fletch A, Wilcox LH, Kinlough-Rathbone RL, Respiratory infection in lipid-fed rabbits enhances sudanophilia and the expression of VCAM-1. Am J Pathol 1997 151 1009 1017
49. Libby P, Inflammation in atherosclerosis. Nature 2002 420 868 874. doi: 10.1038/nature01323
50. Hansson GK, Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005 352 1685 1695. doi: 10.1056/NEJMra043430
51. Tawakol A, Emami H, Farkouh M, Fayad ZA, Fifer K, Rudd JH, Subramanian S, Van Dyke T, Reply: is it not timely to consider how to balance cardiorenometabolic benefits and risks of statins? J Am Coll Cardiol 2014 63 2881
52. Pouliot M, Clish CB, Petasis NA, Van Dyke TE, Serhan CN, Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. Biochemistry 2000 39 4761 4768
53. Kolodgie FD, Katocs AS Jr, Largis EE, Wrenn SM, Cornhill JF, Herderick EE, Lee SJ, Virmani R, Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol. Methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type. Arterioscler Thromb Vasc Biol 1996 16 1454 1464